IB Delta Suite

Imaging Biometrics

IB Delta Suite offers automated quantitative Delta T1 maps for measurement of brain tumor volumes in monitoring treatment response.

Product specifications

Information source: Vendor
Last updated: July 31, 2020

General
Product name	IB Delta Suite
Company	Imaging Biometrics
Subspeciality	Neuro
Modality	MR
Disease targeted	Neuro lesions
Key-features	Image standardization, Delta T1 maps
Suggested use
Data characteristics
Population	Neuro exams
Input	T1-weighted, pre- and post-contrast images
Input format	DICOM
Output	Quantitative Delta T1 maps
Output format	DICOM (RGB and monochrome)
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Hybrid solution, multiple channel partners
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	< 3 sec
Certification
CE	Certified, Class I
FDA	510(k) cleared, Class II
Market presence
On market since	01-2013
Distribution channels	Eureka Clinical AI, QMENTA, Blackford Analysis, Medimsight, CorTechs Labs, aycan Medical Systems, Pixmeo
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription, Traditional license (upfront payment plus annual maintenance)
Based on	Number of users, Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance	Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network (read)
Non-peer reviewed papers on performance
Other relevant papers